Thyrocare Technologies Limited: Bid/Offer to open on Wednesday, April 27, 2016 and to close on Friday, April 29, 2016. Price Band fixed from Rs. 420 to Rs. 446 per Equity Share.
Mumbai, April 20, 2016: Thyrocare Technologies Limited (the “Company” or “Issuer”) will open on Wednesday, April 27, 2016, a Public Offer of up to 10,744,708 equity shares of face value of Rs. 10 each (the “Equity Shares”) for cash, at a price band of between Rs. 420 to Rs. 446 per Equity Share, (including share premium per Equity Share) through an offer for sale (the “Offer”) by the selling shareholders – as follows: (i) up to 10,207,472 Equity Shares offered by Agalia Private Limited; (ii) up to 180,000 Equity Shares offered by A. Sundararaju HUF; (iii) up to 180,000 Equity Shares offered by A. Velumani HUF; and; (iv) up to 177,236 Equity Shares offered by Anand Velumani.
Bids can be made for a minimum of 33 Equity Shares and in multiples of 33 Equity Shares thereafter. The Company and the Selling Shareholders may, in consultation with the Book Running Lead Managers (the “BRLMs”), consider participation by Anchor Investors in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended (the “SEBI Regulations”). The Anchor Investor Bid/Offer Period shall be one Working Day prior to the Bid/Offer Opening Date. The Bid/ Offer will close on Friday, April 29, 2016.
The Equity Shares offered through the Offer are proposed to be listed on National Stock Exchange of India Limited (“NSE”) and BSE Limited (“BSE”). For the Offer, NSE shall be the Designated Stock Exchange.
The BRLMs to the Offer are JM Financial Institutional Securities Limited, Edelweiss Financial Services Limited and ICICI Securities Limited.
The Offer is being made through the Book Building Process in accordance with Regulation 26(1) of the SEBI Regulations wherein not more than 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs”), provided that the Company and Selling Shareholders, in consultation with the BRLMs may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis. One-third of the Anchor Investor Portion shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. 5% of the QIB Portion (excluding the Anchor Investor Portion) shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Price. Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders in accordance with the SEBI Regulations, subject to valid Bids being received at or above the Offer Price. All potential Bidders, other than Anchor Investors, are mandatorily required to utilize the Application Supported by Blocked Amount (“ASBA”) process providing details of their respective bank accounts which will be blocked by the relevant SCSBs to participate in the Offer. Anchor Investors are not permitted to participate in the Offer through ASBA process.